Related Experiment Videos
Using multiple 'omics strategies for novel therapies in sepsis
James A Russell1, Peter Spronk2, Keith R Walley3,2
1Division of Critical Care Medicine, Centre for Heart Lung Innovation, St. Paul's Hospital, 1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada. Jim.Russell@hli.ubc.ca.
Intensive Care Medicine
|March 17, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Plasma apolipoprotein A-I is a causal protective factor in sepsis.
Scientific reports·2025
Obesity- and Lipid-Related Traits May Causally Contribute to Sepsis-Associated Acute Kidney Injury.
Critical care medicine·2025
Corticosteroids in ARDS: old controversies, new insights, and future directions.
Intensive care medicine·2026
Intracranial pressure physiology, monitoring and individualized management in the acute brain injured patient.
Intensive care medicine·2026
Prone positioning in ARDS.
Intensive care medicine·2026
RETRACTION: Up-regulated Mir-192-5p Expression Rescues Cognitive Impairment and Restores Neural Function in Mice With Depression via the Fbln2 -mediated TGF-β1 Signaling Pathway.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Therapeutic Advances and Biomarkers in Multiple Sclerosis.
Current neuropharmacology·2026